Positron emission tomography for molecular imaging of prostate cancer / 中华男科学杂志
National Journal of Andrology
; (12): 1039-1042, 2014.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-319571
Responsible library:
WPRO
ABSTRACT
Prostate cancer is the most common malignancy in the urinary system of males. The remarkable biological and clinical heterogeneity of prostate cancer poses challenges to the initial diagnosis, differential diagnosis, treatment, and prognosis of the disease. Positron emission tomography/computed tomography (PET/CT) is an ideal imaging tool for noninvasive interrogation of underlying tumor biology. Recently, there are a variety of molecular imaging paths and radiopharmaceuticals for the diagnosis and treatment of prostate cancer. This article reviews the current state and prospects of the application of PET in the diagnosis of prostate cancer.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Prognosis
/
Prostatic Neoplasms
/
Diagnostic Imaging
/
Tomography, X-Ray Computed
/
Radiopharmaceuticals
/
Positron-Emission Tomography
/
Molecular Imaging
/
Multimodal Imaging
/
Methods
Type of study:
Diagnostic study
/
Prognostic study
Limits:
Humans
/
Male
Language:
Chinese
Journal:
National Journal of Andrology
Year:
2014
Document type:
Article